- Home
- STEC vs RAPT Comparison
STEC vs RAPT Comparison
Compare STEC & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEC
- RAPT
- Stock Information
- Founded
- STEC 2006
- RAPT 2015
- Country
- STEC China
- RAPT United States
- Employees
- STEC N/A
- RAPT N/A
- Industry
- STEC
- RAPT Biotechnology: Pharmaceutical Preparations
- Sector
- STEC
- RAPT Health Care
- Exchange
- STEC NYSE
- RAPT Nasdaq
- Market Cap
- STEC 31.4M
- RAPT 30.8M
- IPO Year
- STEC 2021
- RAPT 2019
- Fundamental
- Price
- STEC $0.73
- RAPT $0.89
- Analyst Decision
- STEC
- RAPT Hold
- Analyst Count
- STEC 0
- RAPT 10
- Target Price
- STEC N/A
- RAPT $5.00
- AVG Volume (30 Days)
- STEC 288.3K
- RAPT 386.3K
- Earning Date
- STEC 12-31-2024
- RAPT 11-12-2024
- Dividend Yield
- STEC N/A
- RAPT N/A
- EPS Growth
- STEC N/A
- RAPT N/A
- EPS
- STEC N/A
- RAPT N/A
- Revenue
- STEC $260,474,693.00
- RAPT N/A
- Revenue This Year
- STEC $9.76
- RAPT N/A
- Revenue Next Year
- STEC $15.85
- RAPT N/A
- P/E Ratio
- STEC N/A
- RAPT N/A
- Revenue Growth
- STEC N/A
- RAPT N/A
- 52 Week Low
- STEC $0.20
- RAPT $0.81
- 52 Week High
- STEC $3.25
- RAPT $27.35
- Technical
- Relative Strength Index (RSI)
- STEC 41.44
- RAPT 36.23
- Support Level
- STEC $0.72
- RAPT $0.84
- Resistance Level
- STEC $0.84
- RAPT $1.18
- Average True Range (ATR)
- STEC 0.11
- RAPT 0.10
- MACD
- STEC -0.01
- RAPT 0.01
- Stochastic Oscillator
- STEC 29.76
- RAPT 17.00
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a customer based technology company. The company is engaged in exploring new opportunities in technology that includes new retail, social e-commerce, metaverse and others.
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.